Medications for Premature Infant

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Premature Infant.

Found 2 Approved Drugs for Premature Infant

Curosurf

Generic Name
Poractant

Curosurf

Generic Name
Poractant
Form: Suspension
Method of administration: Endotracheal
FDA approval date: November 18, 1999
Classification: Surfactant
CUROSURF ® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants. CUROSURF reduces mortality and pneumothoraces associated with RDS. CUROSURF is a surfactant indicated for the rescue treatment, including the reduction of mortality and pneumothoraces, of Respiratory Distress Syndrome (RDS) in premature infants. ( 1 )

Survanta

Generic Name
Beractant

Survanta

Generic Name
Beractant
Form: Suspension
Method of administration: Endotracheal
FDA approval date: July 01, 1991
SURVANTA is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances